TXG
10X Genomics Inc
NASDAQ: TXG · HEALTHCARE · HEALTH INFORMATION SERVICES
$22.05
+9.16% today
Updated 2026-04-30
Market cap
$2.61B
P/E ratio
—
P/S ratio
4.05x
EPS (TTM)
$-0.35
Dividend yield
—
52W range
$8 – $26
Volume
2.4M
10X Genomics Inc (TXG) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$22.05
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$69.50
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.5B | $0.5B | $0.6B | $0.6B | $0.6B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -6.77%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.